Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen

Journal of Extracellular Vesicles

Volumn 3, Issue 1, 2014, Pages

  Fantappiè, Laura ^a   Santis, Micaela de ^a   Chiarot, Emiliano ^b   Carboni, Filippo ^b   Bensi, Giuliano ^b   Jousson, Olivier ^a   Margarit, Immaculada ^b   Grandi, Guido ^a,b  

^a UNIVERSITY OF TRENTO   (Italy)

^b NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

Group A Streptococcus; Group B Streptococcus; Heterologous antigens; Outer membrane vesicles; Periplasmic expression; Vaccines

Indexed keywords

BACTERIAL ANTIGEN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; GENE SEQUENCE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MEMBRANE VESICLE; MOUSE; NONHUMAN; OMPA GENE; OUTER MEMBRANE VESICLE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A; SURVIVAL RATE;

EID: 84976558277     PISSN: None     EISSN: 20013078     Source Type: Journal    
DOI: 10.3402/jev.v3.24015     Document Type: Article

References (43)

1. Kulp A, Kuehn MJ. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Ann Rev Microbiol. 2010;64:163-84.
2. Ellis TN, Kuehn MJ. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev. 2010;74:81-94.
3. Jeffrey W, Schertzer JW, Whiteley M. Bacterial outer membrane vesicles in trafficking, communication and the hostpathogen interaction. J Mol Microbiol Biotechnol. 2013;23: 118-30.
4. Alaniz RC, Deatherage BL, Lara JC, Cookson BT. Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J Immunol. 2007;179:7692-701.
5. Collins BS. Gram-negative outer membrane vesicles in vaccine development. Discov Med. 2011;12:7-15.
6. Lee S-R, Kim S-H, Jeong K-J, Kim K-S, Kim Y-H, Kim S-J, et al. Multi-immunogenic outer membrane vesicles derived from an MsbB-deficient Salmonella enterica serovar typhimurium mutant. J Microbiol Biotechnol. 2009;19:1271-9.
7. Roy K, Hamilton DJ, Munson GP, Fleckenstein JM. Outer membrane vesicles induce immune responses to virulence proteins and protect against colonization by enterotoxigenic Escherichia coli. Clin Vaccine Immunol. 2011;18:1803-8.
8. Roy N, Barman S, Ghosh A, Pal A, Chakraborty K, Das SS, et al. Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model. FEMS Immunol Med Microbiol. 2010;60:18-27.
9. Sanders H, Feavers IM. Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines. Expert Rev Vaccines. 2011; 10:323-34.
10. Ellis TN, Leiman SA, Kuehn MJ. Naturally produced outer membrane vesicles from Pseudomonas aeruginosa elicit a potent innate immune response via combined sensing of both LPS and protein components. Infect Immun. 2010;78: 3822-31.
11. Kaparakis M, Turnbull L, Carneiro L, Firth S, Coleman HA, Parkington HC, et al. Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells. Cell Microbiol. 2010;12:372-85.
12. Kesty NC, Kuehn MJ. Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles. J Biol Chem. 2004;279:2069-76.
13. Schroeder J, Aebischer T. Recombinant outer membrane vesicles to augment antigen-specific live vaccine responses. Vaccine. 2009;27:6748-54.
14. Kim J-Y, Doody AM, Chen DJ, Cremona GH, Shuler ML, Putnam D, et al. Engineered bacterial outer membrane vesicles with enhanced functionality. J Mol Biol. 2008;380:51-66.
15. Chen DJ, Osterrieder N, Metzger SM, Buckles E, Doody AM, DeLisa MP, et al. Delivery of foreign antigens by engineered outer membrane vesicle vaccines. Proc Natl Acad Sci USA. 2010;107:3099-104.
16. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
17. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA. 2000;97:6640-5.
18. Murphy KC. Use of bacteriophage lambda recombination functions to promote gene replacement in Escherichia coli. J Bacteriol. 1998;180:2063-71.
19. Bensi G, Mora M, Tuscano G, Biagini M, Chiarot E, Bombaci M, et al. Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case. Mol Cell Proteomics. 2012;11:M111. 015693 doi: 10.1074/mcp.M111.015693.
20. Chiarot E, Faralla C, Chiappini N, Tuscano G, Falugi F, Gambellini G, et al. Targeted amino acid substitutions impair streptolysin O toxicity and Group A Streptococcus virulence. MBio. 2013;4:1-9.
21. Klock HE, Lesley SA. The Polymerase Incomplete Primer Extension (PIPE) method applied to high-throughput cloning and site-directed mutagenesis. Methods Mol Biol. 2009;498: 91-103.
22. Edwards RJ, Taylor GW, Ferguson M, Murray S, Rendell N, Wrigley A, et al. Specific C-terminal cleavage and inactivationof interleukin-8 by invasive disease isolates of Streptococcus pyogenes. J Infect Dis. 2005;192:783-90.
23. Alouf JE. Streptococcal toxins (streptolysin O, streptolysin S, erythrogenic toxin). Pharmacol Ther. 1980;11:661-717.
24. Margarit I, Rinaudo CD, Galeotti CL, Maione D, Ghezzo C, Buttazzoni E, et al. Preventing bacterial infections with pilusbased vaccines: the Group B Streptococcus paradigm. J Infect Dis. 2009;199:108-15.
25. Ciofu O, Beveridge TJ, Kadurugamuwa J, Walther-Rasmussen J, Høiby N. Chromosomal beta-lactamase is packaged into membrane vesicles and secreted from Pseudomonas aeruginosa. J Antimicrob Chemother. 2000;45:9-13.
26. Schaar V, Nordström T, Mörgelin M, Riesbeck K. Moraxella catarrhalis outer membrane vesicles carry b-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin. Antimicrob Agents Chemother. 2011;55:3845-53.
27. Bartolini E, Ianni E, Frigimelica E, Petracca R, Galli G, Scorza FB, et al. Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro. J Extracell Vesicles. 2013;2:20181, doi: http://dx.doi.org/10.3402/jev.v2i0.20181.
28. Zingaretti C, Falugi F, Nardi-Dei V, Pietrocola G, Mariani M, Liberatori S, et al. Streptococcus pyogenes SpyCEP: a chemokine-inactivating protease with unique structural and biochemical features. FASEB J. 2010;24:2839-48.
29. Kim OY, Hong BS, Park K-S, Yoon YJ, Choi SJ, Lee WH, et al. Immunization with Escherichia coli outer membrane vesicles protects bacteria-induced lethality via Th1 and Th17 cell responses. J Immunol. 2013;190:4092-102.
30. Snapper CM, Mond JJ. Towards a comprehensive view of immunoglobulin class switching. Immunol Today. 1993;14: 15-7.
31. Snapper CM, Paul WE. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate ig isotype control. Science. 1987;239:944-7.
32. Schild S, Nelson EJ, Bishop AL, Camilli A. Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera. Infect Immun. 2009;77:472-84.
33. Muralinath M, Kuehn MJ, Roland KL, Curtiss R. Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae. Infect Immun. 2011;79:887-94.
34. Sidhu VK, Vorhölter F-J, Niehaus K, Watt SA. Analysis of outer membrane vesicle associated proteins isolated from the plant pathogenic bacterium Xanthomonas campestris pv. campestris. BMC Microbiol. 2008;8:87. doi: 10.1186/1471-2180-8-87.
35. Chatzi KE, Sardis MF, Karamanou S, Economou A. Breaking on through to the other side: protein export through the bacterial Sec system. Biochem J. 2013;449:25-37.
36. Papanikou E, Karamanou S, Economou A. Bacterial protein secretion through the translocase nanomachine. Nat Rev Microbiol. 2007;5:839-51.
37. Von Heijne G, Abrahmsén L. Species-specific variation in signal peptide design. Implications for protein secretion in foreign hosts. FEBS Lett. 1989;244:439-46.
38. Wagner H. The immunogenicity of CpG-antigen conjugates. Adv Drug Deliv Rev. 2009;1:243-7.
39. McBroom AJ, Kuehn MJ. Release of outer membrane vesicles by Gram-negative bacteria is a novel envelope stress response. Mol Microbiol. 2007;63:545-58.
40. Park K-S, Choi K-H, Kim Y-S, Hong BS, Kim OY, Kim JH, et al. Outer membrane vesicles derived from Escherichia coli induce systemic inflammatory response syndrome. PLoS One. 2010;5:e11334.
41. Van der Lay P, Van den Dobbelsteen G. Next-generation outer membrane vesicle vaccines against Neisseria meningitidis based on nontoxic LPS mutants. Human Vaccines. 2011;7: 886-90.
42. Lee DH, Kim S-H, Kang W, Choi YS, Lee S-H, Lee S-R, et al. Adjuvant effect of bacterial outer membrane vesicles with penta-acylated lipopolysaccharide on antigen-specific T cell priming. Vaccine. 2011;29:8293-301.
43. Needham BD, Carroll SM, Giles DK, Georgiou G, Whiteley M, Trent MS. Modulating the innate immune response by combinatorial engineering of endotoxin. Proc Natl Acad Sci USA. 2013;110:1464-9.